BioTech Blogs and Articles

Ziftomenib
BlogJan 21, 2026

Ziftomenib

Ziftomenib (Komzifti®), an oral menin‑KMT2A inhibitor, received FDA approval in November 2025 for adults with relapsed or refractory acute myeloid leukemia (AML) harboring NPM1 mutations. The drug blocks the menin‑KMT2A protein interaction, disrupting leukemogenic transcription programs. In the Phase 1/2 KOMET‑001...

By Drug Hunter
Exercise Reduces Immunosenescence
BlogJan 21, 2026

Exercise Reduces Immunosenescence

Regular physical activity mitigates immunosenescence, restoring immune competence in older adults. Exercise improves insulin sensitivity, modulates mTOR/AMPK pathways, and reduces chronic inflammation. Metabolic remodeling, myokine release, and gut microbiota shifts enhance both innate and adaptive immunity, increasing naive T‑cell output....

By Fight Aging!
Reversing Loss of Titin Elasticity to Improve the Function of Aged Hearts
BlogJan 21, 2026

Reversing Loss of Titin Elasticity to Improve the Function of Aged Hearts

Heart failure with preserved ejection fraction (HFpEF) is driven in part by stiff titin isoforms. Researchers showed that partially inhibiting the splicing regulator RBM20 with antisense oligonucleotides shifts titin expression toward more compliant N2BA‑N isoforms. In a mouse model mimicking...

By Fight Aging!
Mansoor Amiji: Rare Gem and Modern-Day Polymath
BlogJan 21, 2026

Mansoor Amiji: Rare Gem and Modern-Day Polymath

Mansoor Amiji, a Tanzanian‑born nanomedicine researcher, was named a Fellow of the National Academy of Inventors in December 2025, recognizing three decades of vaccine and drug‑delivery innovations. Simultaneously, a deep‑dive review reveals 31 of his publications flagged on PubPeer for image...

By For Better Science
Nanoparticles that Shrink over Time Deliver Eye Drugs to the Retina without Injections
BlogJan 21, 2026

Nanoparticles that Shrink over Time Deliver Eye Drugs to the Retina without Injections

Researchers at Wenzhou Medical University have engineered size‑evolving nanoparticles that can be administered as eye drops to deliver the anti‑VEGF protein bevacizumab to the retina. The particles begin at roughly 214 nm, linger on the ocular surface, and shrink to about...

By Nanowerk
PDI Overexpression Improves Vascular Contractility in Aged Blood Vessels
BlogJan 20, 2026

PDI Overexpression Improves Vascular Contractility in Aged Blood Vessels

Researchers discovered that overexpressing protein disulfide isomerase (PDI) restores contractile function in aged vascular smooth muscle. The study links age‑related loss of sulfenylation‑dependent actin remodeling to reduced arterial stiffness. In murine models, PDI overexpression re‑established F‑actin assembly and rescued vessel...

By Fight Aging!
A Trade-Off Coming Back to Haunt Bispecific Antibody Development
BlogJan 20, 2026

A Trade-Off Coming Back to Haunt Bispecific Antibody Development

Bispecific antibody programs are increasingly confronting early platform decisions that were once deemed interchangeable. Choices made to simplify development or streamline regulatory pathways have embedded mechanistic assumptions that now limit efficacy ceilings and differentiation. As multiple immuno‑oncology bispecifics converge on...

By Biotech Strategy Blog
Aficamten (CK-3773274)
BlogJan 20, 2026

Aficamten (CK-3773274)

Cytokinetics’ aficamten (Myqorzo®) received FDA approval as an oral cardiac myosin inhibitor for obstructive hypertrophic cardiomyopathy (oHCM). The drug is a next‑generation, reversible, allosteric inhibitor designed to simplify dose‑titration compared with the existing agent mavacamten. In a Phase 3 trial, aficamten...

By Drug Hunter
A Discovery Platform for Transcription Factors Capable of Tissue Rejuvenation
BlogJan 20, 2026

A Discovery Platform for Transcription Factors Capable of Tissue Rejuvenation

Researchers introduced a high‑throughput discovery platform that screens individual transcription factors for their ability to reverse cellular aging. Using aged human fibroblasts, the system highlighted more than a dozen candidates and rigorously validated four—E2F3 and EZH2 (activation) and STAT3 and...

By Fight Aging!
Caudate Nucleus Blood Flow and Connectivity Correlate with Grip Strength
BlogJan 20, 2026

Caudate Nucleus Blood Flow and Connectivity Correlate with Grip Strength

Researchers used functional MRI to examine brain activity in older adults performing maximum grip strength tests. Among dozens of regions, the caudate nucleus showed the strongest correlation with grip strength. In a sample of 60 participants equally split by gender,...

By Fight Aging!
Dual Closed-Loop Insulin System Adds Chemical Safeguard to Protect Against Dangerous Overdoses
BlogJan 19, 2026

Dual Closed-Loop Insulin System Adds Chemical Safeguard to Protect Against Dangerous Overdoses

Researchers unveiled a wearable dual closed‑loop insulin system that combines a Transformer‑based AI controller with a glucose‑responsive polymer insulin. The chemical safeguard releases insulin only when blood glucose rises, while the AI predicts glucose trends and directs pump delivery. In...

By Nanowerk
How Best to Assess Molecular Shapeliness?
BlogJan 19, 2026

How Best to Assess Molecular Shapeliness?

The recent open‑access Drug Discovery Today paper evaluates three common metrics for quantifying molecular three‑dimensionality: fraction of sp3‑hybridized carbons (FCsp3), plane of best fit (PBF), and principal moments of inertia (PMI) expressed as ΣNPR. An analysis of half a million...

By Practical Fragments
Atomic Force Microscopy Reveals Nanoscopic Raft Dynamics on Cell Membranes
BlogJan 19, 2026

Atomic Force Microscopy Reveals Nanoscopic Raft Dynamics on Cell Membranes

Scientists at National Taiwan University combined atomic force microscopy with a Hadamard product‑based image reconstruction algorithm to directly visualize membrane raft dynamics on live cells for the first time. The study captured the formation, fusion, and dissolution of nanoscopic rafts...

By Nanowerk
An Intracellular Antibody for Α-Synuclein Improves Motor Function in Aged Rats
BlogJan 19, 2026

An Intracellular Antibody for Α-Synuclein Improves Motor Function in Aged Rats

Researchers used an adeno‑associated virus to deliver the NAC32 intrabody into the substantia nigra of aged rats, achieving a marked reduction in α‑synuclein accumulation. The treatment restored tyrosine hydroxylase expression, raised striatal dopamine levels, and significantly improved locomotor performance without...

By Fight Aging!
Mechanisms of Aging in the Vasculature and Immune System in the Context of Hypertension
BlogJan 19, 2026

Mechanisms of Aging in the Vasculature and Immune System in the Context of Hypertension

The review highlights chronic inflammation as a central driver of vascular dysfunction in hypertension, emphasizing a feedback loop where immune dysregulation impairs hematopoiesis in the bone marrow, which in turn fuels further inflammation. It details how oxidative stress and endothelial...

By Fight Aging!
Weekly Reads: FDA Politics, Lineage Cell Update, Tuft Cells & Cancer, Neuron Mitochondrial Transfer, Dead Celeb Genomics
BlogJan 18, 2026

Weekly Reads: FDA Politics, Lineage Cell Update, Tuft Cells & Cancer, Neuron Mitochondrial Transfer, Dead Celeb Genomics

The blog spotlights a surge of political influence at the FDA, noting RFK Jr.'s role in reshaping policy and even removing a warning on dubious autism therapies. It highlights Lineage Cell’s receipt of a gene‑edited hypoimmune iPSC line from Factor Bioscience,...

By The Niche
Upcoming US Clinical Trial to Test a Tiny Eye Implant that Could Restore Sight for Age-Related Macular Degeneration (AMD)
BlogJan 16, 2026

Upcoming US Clinical Trial to Test a Tiny Eye Implant that Could Restore Sight for Age-Related Macular Degeneration (AMD)

USC’s Roski Eye Institute, together with Regenerative Patch Technologies, is launching a phase 2b, multicenter, masked clinical trial of a stem‑cell‑derived retinal pigment epithelium (RPE) implant for advanced dry age‑related macular degeneration (AMD). The ultra‑thin patch, derived from embryonic stem...

By FrogHeart
Delgocitinib
BlogJan 16, 2026

Delgocitinib

In July 2025, the FDA granted approval to delgocitinib (Anzupgo®), a topical pan‑JAK inhibitor, for adult chronic hand eczema unresponsive or unsuitable for corticosteroids. Developed by Japan Tobacco and Leo Pharma, the formulation delivers the drug directly to affected skin,...

By Drug Hunter
Is AstraZeneca’s Surovatamig Underappreciated?
BlogJan 16, 2026

Is AstraZeneca’s Surovatamig Underappreciated?

AstraZeneca’s head of Oncology Commercial labeled its early‑stage candidate surovatamig ‘underappreciated’ during the J.P. Morgan Healthcare conference, prompting analysts to reassess the drug’s market potential. The comment followed the presentation of phase 1 data at the American Society of Hematology meeting, where...

By Biotech Strategy Blog
Resistance Exercise Improves Cognitive Function in Older Adults
BlogJan 16, 2026

Resistance Exercise Improves Cognitive Function in Older Adults

A meta‑analysis of 17 randomized controlled trials involving 739 older adults found that resistance exercise modestly improves overall cognitive function (SMD = 0.40). Significant gains were observed in working memory (SMD = 0.44), verbal learning (MD = 3.01), and spatial memory span (SMD = 0.63), while processing speed,...

By Fight Aging!
The We Want Them Infected Movement Isn’t Just for COVID Anymore
BlogJan 16, 2026

The We Want Them Infected Movement Isn’t Just for COVID Anymore

The U.S. Centers for Disease Control and Prevention recently trimmed the routine childhood vaccine schedule, dropping three previously recommended immunizations—hepatitis A, hepatitis B, and rotavirus—reducing the total from 18 to 11 vaccines. The change aligns the U.S. schedule more closely with Denmark’s...

By Science-Based Medicine
Yet Another New Biotech Company Aims at Regeneration of the Atrophied Thymus
BlogJan 15, 2026

Yet Another New Biotech Company Aims at Regeneration of the Atrophied Thymus

Swiss biotech TECregen announced seed financing to launch a pipeline of biologic drugs aimed at regenerating the aged thymus. The company’s “thymopoietics” are engineered growth‑factor molecules designed to rebuild thymic epithelial cells, the niche essential for T‑cell maturation. By concentrating...

By Fight Aging!
Acoltremon (AR-15512)
BlogJan 15, 2026

Acoltremon (AR-15512)

Alcon, Aerie Pharmaceuticals, and Avizorex Pharma announced FDA approval of acoltremon (Tryptyr®), the first‑in‑class TRPM8 thermoreceptor agonist for dry eye disease. The ophthalmic solution activates corneal nerves to boost natural tear production, offering a novel mechanism compared with existing anti‑inflammatory...

By Drug Hunter
DIY Botox: Why Self-Injecting a Neurotoxin Is a Terrible Idea
BlogJan 15, 2026

DIY Botox: Why Self-Injecting a Neurotoxin Is a Terrible Idea

TikTok and other platforms are fueling a surge in DIY Botox, where consumers purchase unapproved botulinum toxin online and self‑inject it. In late 2025 the FDA issued warning letters to 18 websites selling counterfeit or misbranded products, citing adverse events...

By Science-Based Medicine
Investigating the Epigenetics of Cellular Senescence in T Cells
BlogJan 15, 2026

Investigating the Epigenetics of Cellular Senescence in T Cells

The paper examines epigenetic regulation of senescence in CD8+ T cells from younger and older donors, revealing that the senescent state, rather than chronological age, drives the majority of epigenomic and transcriptional shifts. Approximately 40% of detectable transcription factors are...

By Fight Aging!
A Beneficial Function of TGF-Β in Aging
BlogJan 15, 2026

A Beneficial Function of TGF-Β in Aging

Researchers discovered that transforming growth factor‑beta (TGF‑β) signaling in microglia acts as a protective checkpoint for myelin integrity in the aging spinal cord. In aged mice, the dorsal column showed pronounced myelin degeneration alongside heightened TGF‑β activity in resident microglia....

By Fight Aging!
Thoughts on Aging as Damage versus Aging as a Program of Altered Gene Expression
BlogJan 14, 2026

Thoughts on Aging as Damage versus Aging as a Program of Altered Gene Expression

The article contrasts two dominant aging paradigms—damage accumulation and programmed gene‑expression—and highlights a growing synthesis of the two. It explains that a damage view drives research toward repair mechanisms, while a program view pushes gene‑expression and metabolic re‑engineering. Recent discoveries,...

By Fight Aging!
Mechanotransduction via Piezo1 Drives the Benefits of Exercise on Bone Tissue
BlogJan 14, 2026

Mechanotransduction via Piezo1 Drives the Benefits of Exercise on Bone Tissue

Researchers identified the mechanosensitive ion channel Piezo1 in bone‑marrow mesenchymal stem cells as the key mediator of exercise‑induced bone health. Mechanical loading activates Piezo1, which suppresses marrow adipogenesis, curtails a Ccl2‑Lcn2 inflammatory loop, and promotes osteoblast differentiation. Mice lacking Piezo1...

By Fight Aging!
Common Changes in RNA Splicing and Processing with Age Across Tissues
BlogJan 14, 2026

Common Changes in RNA Splicing and Processing with Age Across Tissues

Researchers applied differential network analysis to human transcriptomes (ages 20‑70) across multiple tissues, uncovering age‑related transcriptional changes that standard differential expression missed. By integrating both methods, they identified a core set of genes consistently modulated with age, heavily enriched for...

By Fight Aging!
When the Boat Matters More than You Think
BlogJan 13, 2026

When the Boat Matters More than You Think

Two biotech firms announced phase‑3 oncology trials in San Francisco, enrolling fewer than 20 and fewer than 50 patients respectively. The ultra‑small cohorts reflect a growing trend to accelerate drug development for rare cancers, leveraging expedited regulatory pathways. While the approach...

By Biotech Strategy Blog
Reviewing the Use of Fecal Microbiota Transplantation to Treat Parkinson's Disease
BlogJan 13, 2026

Reviewing the Use of Fecal Microbiota Transplantation to Treat Parkinson's Disease

Recent research highlights the gut‑brain axis as a key factor in Parkinson’s disease, where age‑related dysbiosis may exacerbate neurodegeneration. Small clinical trials of fecal microbiota transplantation (FMT) have shown restored microbial balance, reduced constipation, and measurable improvements in motor, cognitive,...

By Fight Aging!
The Consumer Frontier
BlogJan 13, 2026

The Consumer Frontier

The episode explores the "consumer frontier"—the point where technology becomes culture—as it shifts from software to hardware (atoms) and then to biology (cells). It explains how lowering technological difficulty and rising cultural readiness have turned software into pop culture, and...

By Arm the Creators
Treosulfan (NSC 39069)
BlogJan 13, 2026

Treosulfan (NSC 39069)

Treosulfan (Grafapex®) received FDA approval in 2025 when combined with fludarabine as a conditioning regimen for allogeneic stem‑cell transplantation (alloHSCT) in patients aged one year and older with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). The approval follows trials...

By Drug Hunter
Addgene’s Expanding Collection of Research Tools for Industry Scientists
BlogJan 13, 2026

Addgene’s Expanding Collection of Research Tools for Industry Scientists

Addgene, celebrating two decades of plasmid distribution, now offers nearly 10,000 unique research tools to industry scientists. The collection spans fluorescent protein plasmids, AI‑generated CRISPR editors, enzyme‑producing vectors, viral‑vector kits, and extensive antibody libraries. New filters on the Addgene website...

By Addgene Blog
LINE-1 RNA Provokes Inflammation to Contribute to Cognitive Dysfunction
BlogJan 13, 2026

LINE-1 RNA Provokes Inflammation to Contribute to Cognitive Dysfunction

Researchers identified plasma extracellular vesicle (EV) LINE‑1 RNA as a potent systemic aging factor that rises sharply with age and correlates with brain‑aging biomarkers. In mouse models, aged EVs cross the blood‑brain barrier, deliver LINE‑1 RNA to microglia, and activate...

By Fight Aging!
Interactions Between Gut Microbiome and Muscle Tissue in the Development of Sarcopenia
BlogJan 13, 2026

Interactions Between Gut Microbiome and Muscle Tissue in the Development of Sarcopenia

Researchers highlight a bidirectional link between the aging gut microbiome and skeletal muscle, where myokine signaling shapes microbial composition and microbial metabolites influence muscle mass. Dysbiosis and reduced myokine secretion create a vicious cycle that accelerates sarcopenia. Interventions that modulate...

By Fight Aging!
Arguing for Sirtuins to Be Involved in Known Interventions to Modestly Slow Vascular Calcification
BlogJan 12, 2026

Arguing for Sirtuins to Be Involved in Known Interventions to Modestly Slow Vascular Calcification

Vascular calcification, a hallmark of cardiovascular aging, lacks effective reversal therapies beyond modest chelation. A new open‑access study links the SIRT family of proteins to slowed calcification by modulating inflammation, oxidative stress, and ferroptosis, primarily through metformin‑driven activation of SIRT1...

By Fight Aging!
An Opinionated View of Current Issues with Aging Clocks
BlogJan 12, 2026

An Opinionated View of Current Issues with Aging Clocks

Aging clocks aim to quantify biological age using molecular data, promising faster assessment of anti‑aging therapies. While dozens of clocks exist, they are currently trusted only for research and personal health monitoring, not for regulatory or clinical decision‑making. The blog...

By Fight Aging!
Weekly Reads: Organoids ‘Pregnant’ with Human Embryos, Neuralink, Biotech Scorecard, Iffy Autism Tests
BlogJan 11, 2026

Weekly Reads: Organoids ‘Pregnant’ with Human Embryos, Neuralink, Biotech Scorecard, Iffy Autism Tests

Researchers have successfully co‑cultured human embryos with endometrial organoids, creating a 3‑dimensional post‑implantation model that mimics early pregnancy. The study, published in Cell Stem Cell, shows embryos can organize with organoid tissue for several days, offering a new platform for...

By The Niche
Relief From Tooth Sensitivity with Magnetically Guided Nanobots
BlogJan 9, 2026

Relief From Tooth Sensitivity with Magnetically Guided Nanobots

Researchers at IISc and deep‑tech startup Theranautilus have engineered CalBots, magnetic nanobots that penetrate dentinal tubules and form durable bioceramic seals to alleviate tooth hypersensitivity. The 400‑nm particles are guided by an external magnetic field, reaching depths of 300‑500 µm and...

By FrogHeart
Dementia Risk Varies Between Strong versus Weak Circadian Clock Regulation
BlogJan 9, 2026

Dementia Risk Varies Between Strong versus Weak Circadian Clock Regulation

A new open‑access study of 2,183 older adults found that individuals with stronger circadian rhythms have a markedly lower risk of developing dementia. Researchers quantified rhythm strength using the relative amplitude of activity‑rest cycles derived from heart‑monitor and accelerometer data,...

By Fight Aging!
A Bioinspired Hydrogel Patch with Controllable Adhesion Properties for Enhanced Soft Tissue Repair
BlogJan 9, 2026

A Bioinspired Hydrogel Patch with Controllable Adhesion Properties for Enhanced Soft Tissue Repair

Researchers from Shenzhen University, the Chinese Academy of Sciences and Hong Kong Polytechnic University have created a bioinspired hydrogel patch with controllable adhesion for soft tissue repair. The dual‑sided device combines a suction‑cup‑like adhesive layer that can be repositioned and...

By FrogHeart
Camizestrant
BlogJan 9, 2026

Camizestrant

Camizestrant is an oral, selective estrogen‑receptor‑alpha (ERα) degrader developed by AstraZeneca for ER‑positive, HER2‑negative, ESR1‑mutated breast cancer. The drug advanced to a Phase 3 trial, with results published in the New England Journal of Medicine in June 2025. The study demonstrated a...

By Drug Hunter
A Bear’s Eye View of the Zanidatamab Data in Gastric Cancer
BlogJan 9, 2026

A Bear’s Eye View of the Zanidatamab Data in Gastric Cancer

Jazz Pharmaceuticals presented zanidatamab data from the HERIZON‑GEA‑01 phase 3 trial at the ASCO GI Symposium, targeting HER2‑positive gastric cancer. The company touted the results as practice‑changing, prompting sell‑side analysts to echo the optimism. However, the stock fell 4‑5% as investors...

By Biotech Strategy Blog
Retro Biosciences Starts a Safety Trial for an Autophagy Promoter
BlogJan 9, 2026

Retro Biosciences Starts a Safety Trial for an Autophagy Promoter

Retro Biosciences has initiated a Phase 1 safety trial of its small‑molecule autophagy promoter RTR242 in healthy volunteers in Australia. The drug is designed to restore lysosomal acidity, thereby enhancing cellular waste‑clearance mechanisms that decline with age. The study is randomized,...

By Fight Aging!
Dr. Marty Makary Was Paid $130,357 By Pharma.  Is His “Undue Influence” Affecting the FDA?
BlogJan 9, 2026

Dr. Marty Makary Was Paid $130,357 By Pharma.  Is His “Undue Influence” Affecting the FDA?

Dr. Marty Makary, now FDA commissioner, earned $130,357 from pharma firms before his nomination and serves on the board of an ophthalmic drug company despite pledging never to work for big‑pharma. He appointed former industry executive Dr. George Tidmarsh to...

By Science-Based Medicine
In Search of Mechanisms to Explain the Sex Difference in Alzheimer's Disease Outcomes
BlogJan 8, 2026

In Search of Mechanisms to Explain the Sex Difference in Alzheimer's Disease Outcomes

Recent open‑access research confirms that women experience more severe Alzheimer’s pathology than men, with female 5xFAD mice developing larger, less compact amyloid‑β plaques. Transcriptomic analysis revealed that female microglia up‑regulate glycolytic metabolism, antigen‑presentation pathways, and a distinct type‑I interferon signature,...

By Fight Aging!
Healing Brain Cells and Tackling Neurodegenerative Diseases with Nanoflowers
BlogJan 8, 2026

Healing Brain Cells and Tackling Neurodegenerative Diseases with Nanoflowers

Researchers at Texas A&M have shown that metallic “nanoflower” nanoparticles can protect and repair brain cells by improving mitochondrial health. In cell cultures, the nanoflowers sharply lowered reactive oxygen species and enhanced mitochondrial integrity within a day, and in C....

By FrogHeart
Top 10 Most Popular Drug Hunter Resources of 2025
BlogJan 8, 2026

Top 10 Most Popular Drug Hunter Resources of 2025

Drug Hunter’s 2025 resource roundup highlights the ten most accessed tools that support daily drug‑discovery workflows. The suite includes practical PK calculators, bioisostere and covalent inhibitor cheat sheets, a searchable structure and patent database, and a series of 25 Flash...

By Drug Hunter